# Eduardo López Briz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/eduardo-lopez-briz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,221 |
| Field | Pharmaceutical studies and practices |
| h-index | 19 |
| i10-index | 28 |
| Last Known Institution | Hospital Universitari i Politècnic La Fe |
| OpenAlex ID | https://openalex.org/A5080978486 |
| ORCID iD | 0000-0002-6519-522X |
| Works | 149 |

## Researcher papers

- [Megestrol acetate for treatment of anorexia-cachexia syndrome](https://scholariq.org/papers/megestrol-acetate-for-treatment-of-anorexia-cachexia-syndrome/)
- [Megestrol acetate for cachexia–anorexia syndrome. A systematic review](https://scholariq.org/papers/megestrol-acetate-for-cachexia-anorexia-syndrome-a-systematic-review/)
- [2013. Documento Sevilla de Consenso sobre Alternativas a la Transfusión de Sangre Alogénica. Actualización del Documento Sevilla](https://scholariq.org/papers/2013-documento-sevilla-de-consenso-sobre-alternativas-a-la-transfusion-de-sangre/)
- [Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults](https://scholariq.org/papers/heparin-versus-0-9-sodium-chloride-locking-for-prevention-of-occlusion-in/)
- [Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults](https://scholariq.org/papers/heparin-versus-0-9-sodium-chloride-intermittent-flushing-for-prevention-of/)
- [Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19](https://scholariq.org/papers/involvement-of-interleukin-6-in-sars-cov-2-infection-siltuximab-as-a-therapeutic/)
- [A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain](https://scholariq.org/papers/a-systematic-review-and-meta-analysis-of-the-effectiveness-and-adverse-events-of/)
- [Peripheral endothelial progenitor cells (CD133+) for therapeutic vasculogenesis in a patient with critical limb ischemia. One year follow-up](https://scholariq.org/papers/peripheral-endothelial-progenitor-cells-cd133-for-therapeutic-vasculogenesis-in/)
- [Trans-arterial chemoembolization with doxorubicin-eluting particles versus conventional trans-arterial chemoembolization in unresectable hepatocellular carcinoma: A study of effectiveness, safety and costs](https://scholariq.org/papers/trans-arterial-chemoembolization-with-doxorubicin-eluting-particles-versus/)
- [Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann–Pick type C disease: review of initial published cases](https://scholariq.org/papers/early-experience-with-compassionate-use-of-2-hydroxypropyl-beta-cyclodextrin-for/)
- [4CPS-096 Teduglutide versus home parenteral nutrition in paediatric population with short bowel syndrome](https://scholariq.org/papers/4cps-096-teduglutide-versus-home-parenteral-nutrition-in-paediatric-population/)

## Researcher topics

- [Pharmaceutical studies and practices](https://scholariq.org/topics/pharmaceutical-studies-and-practices/)
- [Pharmaceutical Practices and Patient Outcomes](https://scholariq.org/topics/pharmaceutical-practices-and-patient-outcomes/)
- [Safe Handling of Antineoplastic Drugs](https://scholariq.org/topics/safe-handling-of-antineoplastic-drugs/)
- [Patient Safety and Medication Errors](https://scholariq.org/topics/patient-safety-and-medication-errors/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

## Researcher university

- [Hospital Universitari i Politècnic La Fe](https://scholariq.org/institutions/hospital-universitari-i-politecnic-la-fe/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.